Cargando…

Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a major cause of cancer mortality and an increasing incidence worldwide; however, there are very few effective diagnostic approaches and prognostic biomarkers. MATERIALS AND METHODS: One hundred forty-nine pairs of HCC samples from Gene Expression Omnibu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yujia, Liu, Yulin, Zhao, Songfeng, Zheng, Zhetian, Shen, Chunyi, An, Li, Yuan, Yongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252784/
https://www.ncbi.nlm.nih.gov/pubmed/30538557
http://dx.doi.org/10.2147/CMAR.S181396
_version_ 1783373343957712896
author Zheng, Yujia
Liu, Yulin
Zhao, Songfeng
Zheng, Zhetian
Shen, Chunyi
An, Li
Yuan, Yongliang
author_facet Zheng, Yujia
Liu, Yulin
Zhao, Songfeng
Zheng, Zhetian
Shen, Chunyi
An, Li
Yuan, Yongliang
author_sort Zheng, Yujia
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is a major cause of cancer mortality and an increasing incidence worldwide; however, there are very few effective diagnostic approaches and prognostic biomarkers. MATERIALS AND METHODS: One hundred forty-nine pairs of HCC samples from Gene Expression Omnibus (GEO) were obtained to screen differentially expressed genes (DEGs) between HCC and normal samples. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, Gene ontology enrichment analyses, and protein–protein interaction network were used. Cox proportional hazards regression analysis was used to identify significant prognostic DEGs, with which a gene expression signature prognostic prediction model was identified in The Cancer Genome Atlas (TCGA) project discovery cohort. The robustness of this panel was assessed in the GSE14520 cohort. We verified details of the gene expression level of the key molecules through TCGA, GEO, and qPCR and used immunohistochemistry for substantiation in HCC tissues. The methylation states of these genes were also explored. RESULTS: Ninety-eight genes, consisting of 13 upregulated and 85 downregulated genes, were screened out in three datasets. KEGG and Gene ontology analysis for the DEGs revealed important biological features of each subtype. Protein–protein interaction network analysis was constructed, consisting of 64 nodes and 115 edges. A subset of four genes (SPINK1, TXNRD1, LCAT, and PZP) that formed a prognostic gene expression signature was established from TCGA and validated in GSE14520. Next, the expression details of the four genes were validated with TCGA, GEO, and clinical samples. The expression panels of the four genes were closely related to methylation states. CONCLUSION: This study identified a novel four-gene signature biomarker for predicting the prognosis of HCC. The biomarkers may also reveal molecular mechanisms underlying development of the disease and provide new insights into interventional strategies.
format Online
Article
Text
id pubmed-6252784
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62527842018-12-11 Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma Zheng, Yujia Liu, Yulin Zhao, Songfeng Zheng, Zhetian Shen, Chunyi An, Li Yuan, Yongliang Cancer Manag Res Original Research BACKGROUND: Hepatocellular carcinoma (HCC) is a major cause of cancer mortality and an increasing incidence worldwide; however, there are very few effective diagnostic approaches and prognostic biomarkers. MATERIALS AND METHODS: One hundred forty-nine pairs of HCC samples from Gene Expression Omnibus (GEO) were obtained to screen differentially expressed genes (DEGs) between HCC and normal samples. The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, Gene ontology enrichment analyses, and protein–protein interaction network were used. Cox proportional hazards regression analysis was used to identify significant prognostic DEGs, with which a gene expression signature prognostic prediction model was identified in The Cancer Genome Atlas (TCGA) project discovery cohort. The robustness of this panel was assessed in the GSE14520 cohort. We verified details of the gene expression level of the key molecules through TCGA, GEO, and qPCR and used immunohistochemistry for substantiation in HCC tissues. The methylation states of these genes were also explored. RESULTS: Ninety-eight genes, consisting of 13 upregulated and 85 downregulated genes, were screened out in three datasets. KEGG and Gene ontology analysis for the DEGs revealed important biological features of each subtype. Protein–protein interaction network analysis was constructed, consisting of 64 nodes and 115 edges. A subset of four genes (SPINK1, TXNRD1, LCAT, and PZP) that formed a prognostic gene expression signature was established from TCGA and validated in GSE14520. Next, the expression details of the four genes were validated with TCGA, GEO, and clinical samples. The expression panels of the four genes were closely related to methylation states. CONCLUSION: This study identified a novel four-gene signature biomarker for predicting the prognosis of HCC. The biomarkers may also reveal molecular mechanisms underlying development of the disease and provide new insights into interventional strategies. Dove Medical Press 2018-11-21 /pmc/articles/PMC6252784/ /pubmed/30538557 http://dx.doi.org/10.2147/CMAR.S181396 Text en © 2018 Zheng et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zheng, Yujia
Liu, Yulin
Zhao, Songfeng
Zheng, Zhetian
Shen, Chunyi
An, Li
Yuan, Yongliang
Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma
title Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma
title_full Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma
title_fullStr Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma
title_full_unstemmed Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma
title_short Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma
title_sort large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252784/
https://www.ncbi.nlm.nih.gov/pubmed/30538557
http://dx.doi.org/10.2147/CMAR.S181396
work_keys_str_mv AT zhengyujia largescaleanalysisrevealsanovelriskscoretopredictoverallsurvivalinhepatocellularcarcinoma
AT liuyulin largescaleanalysisrevealsanovelriskscoretopredictoverallsurvivalinhepatocellularcarcinoma
AT zhaosongfeng largescaleanalysisrevealsanovelriskscoretopredictoverallsurvivalinhepatocellularcarcinoma
AT zhengzhetian largescaleanalysisrevealsanovelriskscoretopredictoverallsurvivalinhepatocellularcarcinoma
AT shenchunyi largescaleanalysisrevealsanovelriskscoretopredictoverallsurvivalinhepatocellularcarcinoma
AT anli largescaleanalysisrevealsanovelriskscoretopredictoverallsurvivalinhepatocellularcarcinoma
AT yuanyongliang largescaleanalysisrevealsanovelriskscoretopredictoverallsurvivalinhepatocellularcarcinoma